Monitoring HIV treatment in developing countries

BMJ. 2006 Mar 11;332(7541):602-4. doi: 10.1136/bmj.332.7541.602.

Abstract

Laboratory monitoring of antiretroviral therapy helps limit resistance but is currently not feasible in developing countries. Alternative short term approaches are needed

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Developing Countries*
  • HIV Infections / drug therapy*
  • Health Services Administration
  • Humans

Substances

  • Anti-HIV Agents